These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11422821)

  • 1. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
    Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
    Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
    Roberts CA; Stern DL; Radio SJ
    Transplantation; 2002 Sep; 74(6):817-21. PubMed ID: 12364862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
    Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
    Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy.
    Pappas PA; Weppler D; Pinna AD; Rusconi P; Thompson JF; Jaffe JS; Tzakis AG
    Pediatr Transplant; 2000 Feb; 4(1):45-9. PubMed ID: 10731058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
    Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
    Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
    Levy G; Villamil F; Samuel D; Sanjuan F; Grazi GL; Wu Y; Marotta P; Boillot O; Muehlbacher F; Klintmalm G;
    Transplantation; 2004 Jun; 77(11):1632-8. PubMed ID: 15201658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
    Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
    Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
    Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
    Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of tacrolimus-induced cardiomyopathy.
    Coley KC; Verrico MM; McNamara DM; Park SC; Cressman MD; Branch RA
    Ann Pharmacother; 2001 Sep; 35(9):985-9. PubMed ID: 11573873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
    Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.